Cargando…
Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228947/ https://www.ncbi.nlm.nih.gov/pubmed/35744055 http://dx.doi.org/10.3390/medicina58060793 |
| _version_ | 1784734609259364352 |
|---|---|
| author | Abdelazeem, Basel Abbas, Kirellos Said Brašić, James Robert |
| author_facet | Abdelazeem, Basel Abbas, Kirellos Said Brašić, James Robert |
| author_sort | Abdelazeem, Basel |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9228947 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92289472022-06-25 Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” Abdelazeem, Basel Abbas, Kirellos Said Brašić, James Robert Medicina (Kaunas) Reply MDPI 2022-06-13 /pmc/articles/PMC9228947/ /pubmed/35744055 http://dx.doi.org/10.3390/medicina58060793 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Reply Abdelazeem, Basel Abbas, Kirellos Said Brašić, James Robert Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” |
| title | Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” |
| title_full | Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” |
| title_fullStr | Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” |
| title_full_unstemmed | Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” |
| title_short | Reply to Aljabali et al. Comment on “Abbas et al. The Safety and Efficacy of Nusinersen in the Treatment of Spinal Muscular Atrophy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicina 2022, 58, 213” |
| title_sort | reply to aljabali et al. comment on “abbas et al. the safety and efficacy of nusinersen in the treatment of spinal muscular atrophy: a systematic review and meta-analysis of randomized controlled trials. medicina 2022, 58, 213” |
| topic | Reply |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228947/ https://www.ncbi.nlm.nih.gov/pubmed/35744055 http://dx.doi.org/10.3390/medicina58060793 |
| work_keys_str_mv | AT abdelazeembasel replytoaljabalietalcommentonabbasetalthesafetyandefficacyofnusinerseninthetreatmentofspinalmuscularatrophyasystematicreviewandmetaanalysisofrandomizedcontrolledtrialsmedicina202258213 AT abbaskirellossaid replytoaljabalietalcommentonabbasetalthesafetyandefficacyofnusinerseninthetreatmentofspinalmuscularatrophyasystematicreviewandmetaanalysisofrandomizedcontrolledtrialsmedicina202258213 AT brasicjamesrobert replytoaljabalietalcommentonabbasetalthesafetyandefficacyofnusinerseninthetreatmentofspinalmuscularatrophyasystematicreviewandmetaanalysisofrandomizedcontrolledtrialsmedicina202258213 |